Click Here for 5% Off Your First Aladdin Purchase!

CP-55,940 - ≥98%, high purity , CAS No.83002-04-4, Agonist of CB 1 receptor;Agonist of CB 2 receptor;Agonist of GPR55;Antagonist of GPR55

  • Moligand™
  • ≥98%
Item Number
C341166
Grouped product items
SKUSizeAvailabilityPrice Qty
C341166-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$199.90
C341166-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$699.90

a cannabimimetic small molecule and potent non-selective cannabinoid receptor agonist

Basic Description

Specifications & Purity≥98%
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeAGONIST, ANTAGONIST
Mechanism of actionAgonist of CB 1 receptor;Agonist of CB 2 receptor;Agonist of GPR55;Antagonist of GPR55
Product Description

CP-55940 is a cannabimimetic small molecule and a potent cannabinoid receptor agonist, demonstrating similar binding activity at both receptor types (CB1 K|i|=0.58 nM, CB2 K|i|=0.69 nM). CP-55940 represents a useful non-selective agonist entry into the growing library of synthetic cannabimimetics, compounds which are being actively explored for efficacy in perturbing Alzheimer′s disease and other neurodegenerative states.

Product Properties

pKapKa: 10.25
Ki Datarecombinant CB1 : Ki= 0.58 nM (human); recombinant CB2: Ki= 0.69 nM (human)

Associated Targets

CNR1 Tclin Cannabinoid receptor 1 2 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CNR2 Tchem Cannabinoid receptor 2 2 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

GPR55 Tclin G-protein coupled receptor 55 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol
INCHI InChI=1S/C24H40O3/c1-4-5-6-7-14-24(2,3)19-11-13-21(23(27)16-19)22-17-20(26)12-10-18(22)9-8-15-25/h11,13,16,18,20,22,25-27H,4-10,12,14-15,17H2,1-3H3
InChi Key YNZFFALZMRAPHQ-UHFFFAOYSA-N
Canonical SMILES CCCCCCC(C)(C)C1=CC(=C(C=C1)C2CC(CCC2CCCO)O)O
Isomeric SMILES CCCCCCC(C)(C)C1=CC(=C(C=C1)C2CC(CCC2CCCO)O)O
WGK Germany 3
RTECS SL1955000
PubChem CID 4412255
MeSH Entry Terms 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol;CP 55940;CP 56667;CP-55,940;CP-56,667;CP55,940;CP55940
Molecular Weight 376.57

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Chemical and Physical Properties

SolubilitySoluble in ethanol, DMSO and DMF all at ~30 mg/ml. Sparingly soluble in aqueous buffers, ethanol:PBS (1:3, pH 7.2, 0.25 mg/ml).
Refractive Indexn20D1.53
Boil Point(°C)~494.4° C at 760 mmHg (Predicted)
Melt Point(°C)212.69° C

Safety and Hazards(GHS)

Hazard Statements

H336:May cause drowsiness or dizziness

WGK Germany 3
RTECS SL1955000
RIDADR NONHforallmodesoftransport

Related Documents

References

1. Kapur A, Zhao P, Sharir H, Bai Y, Caron MG, Barak LS, Abood ME.  (2009)  Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands..  J Biol Chem,  284  (43): (29817-27).  [PMID:19723626]
2. Petitet F, Donlan M, Michel A.  (2006)  GPR55 as a new cannabinoid receptor: still a long way to prove it..  Chem Biol Drug Des,  67  (3): (252-3).  [PMID:16611220]
3. Blaazer AR, Lange JH, van der Neut MA, Mulder A, den Boon FS, Werkman TR, Kruse CG, Wadman WJ.  (2011)  Novel indole and azaindole (pyrrolopyridine) cannabinoid (CB) receptor agonists: design, synthesis, structure-activity relationships, physicochemical properties and biological activity..  Eur J Med Chem,  46  (10): (5086-98).  [PMID:21885167]

Solution Calculators